Sarepta Therapeutics Inc (SRPT)
123.24
-0.05
(-0.04%)
USD |
NASDAQ |
Nov 04, 13:00
Sarepta Therapeutics Gross Profit Margin (Quarterly): 87.73% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 87.73% |
| March 31, 2024 | 87.77% |
| December 31, 2023 | 88.87% |
| September 30, 2023 | 88.84% |
| June 30, 2023 | 86.94% |
| March 31, 2023 | 86.19% |
| December 31, 2022 | 88.08% |
| September 30, 2022 | 82.65% |
| June 30, 2022 | 83.81% |
| March 31, 2022 | 85.09% |
| December 31, 2021 | 84.24% |
| September 30, 2021 | 87.62% |
| June 30, 2021 | 88.11% |
| March 31, 2021 | 84.79% |
| December 31, 2020 | 84.56% |
| September 30, 2020 | 89.57% |
| Date | Value |
|---|---|
| June 30, 2020 | 90.29% |
| March 31, 2020 | 88.90% |
| December 31, 2019 | 84.45% |
| September 30, 2019 | 86.84% |
| June 30, 2019 | 83.18% |
| March 31, 2019 | 86.14% |
| December 31, 2018 | 84.44% |
| September 30, 2018 | 88.86% |
| June 30, 2018 | 90.84% |
| March 31, 2018 | 91.36% |
| December 31, 2017 | 93.81% |
| September 30, 2017 | 93.30% |
| June 30, 2017 | 98.55% |
| March 31, 2017 | 98.64% |
| December 31, 2016 | 98.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
82.65%
Minimum
Sep 2022
90.29%
Maximum
Jun 2020
86.76%
Average
87.62%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
| Regenxbio Inc | 52.55% |
| Catalyst Pharmaceuticals Inc | 87.45% |
| Vertex Pharmaceuticals Inc | 85.94% |
| Entrada Therapeutics Inc | -- |
| Edgewise Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 5.37% |
| Return on Assets | 1.46% |
| Return on Invested Capital | 2.24% |
| Profit Margin (Quarterly) | 1.78% |
| Operating Margin (Quarterly) | -0.19% |
| Return on Net Operating Assets | 3.69% |